Delhi HC OKs Sun Pharma`s Export of Proprietary Weight-Loss Drug
10 Dec 2025 //
ECONOMICTIMES
Novo Nordisk Has Completed Its Acquisition Of Akero Therapeutics
09 Dec 2025 //
GLOBENEWSWIRE
Slimmer price tag helps Wegovy sales gain weight
09 Dec 2025 //
ECONOMICTIMES
Semaglutide Trials Yield Insights for Alzheimer`s Therapies
04 Dec 2025 //
PR NEWSWIRE
Novo Nordisk Justifies Reasoning Behind Failed GLP-1 Alzheimer
02 Dec 2025 //
REUTERS
Omeros Closes Deal With Novo Nordisk For MASP-3 Inhibitor OMS906
01 Dec 2025 //
BUSINESSWIRE
Novo Nordisk Cuts Wegovy Prices, Generic Firms Adjust Pricing
27 Nov 2025 //
ECONOMICTIMES
Novo Nordisk Seeks FDA Approval for Higher 7.2mg Wegovy Dose
26 Nov 2025 //
PR NEWSWIRE
Novo Expands Pivotal Program After Amycretin Shines in Diabetes
25 Nov 2025 //
GLOBENEWSWIRE
Novo Reports 2 Trial Failures For GLP-1 In Alzheimer`s Disease
24 Nov 2025 //
GLOBENEWSWIRE
Biogen`s Leqembi Rises After Novo GLP-1 Fails In Alzheimer
24 Nov 2025 //
BIOSPACE
Semaglutide Compounder Drops Claims After Novo Nordisk Challenge
21 Nov 2025 //
FIERCE PHARMA
Novo Nordisk India Focuses On Patient Outcomes, Revenue Growth
19 Nov 2025 //
ECONOMICTIMES
Eli Lilly, Novo Nordisk Strategize To Defend Top Obesity Drugs
18 Nov 2025 //
ECONOMICTIMES
Novo Sets New Self-Pay Prices For Wegovy, Ozempic
18 Nov 2025 //
FIERCE PHARMA
LifeMD: Best Prices on Wegovy & Ozempic with Novo Nordisk
17 Nov 2025 //
GLOBENEWSWIRE
GoodRx Launches $39/Month Weight Loss Telehealth Plan
17 Nov 2025 //
BUSINESSWIRE
Novo Nordisk A/S EGM Meeting Resolutions Announced
14 Nov 2025 //
GLOBENEWSWIRE
Novo Foundation Concludes Board Takeover Amid Shareholder
14 Nov 2025 //
BIOSPACE
Novo Nordisk: Board Candidate Withdraws From Election
13 Nov 2025 //
GLOBENEWSWIRE
Mangoceuticals Partners with Eli Lilly and Novo Nordisk
13 Nov 2025 //
GLOBENEWSWIRE
Korro Lays Off Staff As Lead Drug Disappoints, Novo Pauses Pact
13 Nov 2025 //
FIERCE BIOTECH
Eli Lilly Ends CVS Drug Plan for Staff After Novo Obesity Deal
12 Nov 2025 //
ECONOMICTIMES
Novo Nordisk Reduces Wegovy Price By 33% In India
11 Nov 2025 //
ECONOMICTIMES
Novo Nordisk: Board Members and Executives Trade Shares
11 Nov 2025 //
GLOBENEWSWIRE
Emcure Partners With Novo To Increase Access To Wegovy In India
11 Nov 2025 //
BUSINESS STD
Search For Next Blockbuster Drug Extends Beyond Weight Loss
10 Nov 2025 //
BIOSPACE
Wegovy Showed Liver Health Benefits In MASH Beyond Weight Loss
10 Nov 2025 //
PR NEWSWIRE
Novo Nordisk Maintains Offer To Acquire Metsera
08 Nov 2025 //
GLOBENEWSWIRE
Pfizer wins $10 billion bidding war for Metsera as Novo Exist
08 Nov 2025 //
REUTERS
Novo Nordisk, Fangzhou Initiate AI Diabetes, Weight Management
07 Nov 2025 //
GLOBENEWSWIRE
Novo Nordisk`s Cagrisema Reduces Blood Pressure
06 Nov 2025 //
PR NEWSWIRE
Novo, Lilly strike Deal with Trump to Slash Drug Price
06 Nov 2025 //
REUTERS
Novo Nordisk Agrees With U.S. Administration To Expand Access
06 Nov 2025 //
GLOBENEWSWIRE
Novo Wegovy Users Hit Waist & BMI Targets Linked To Health
05 Nov 2025 //
GLOBENEWSWIRE
Pfizer Responds To Delaware Chancery Court Ruling
05 Nov 2025 //
BUSINESS WIRE
Novo Nordisk CEO `Feels` Danish Pharma Will Bag Metsera
05 Nov 2025 //
FIERCE BIOTECH
Novo Drops Oncology Ambitions, Early-Stage MASH Prospects
05 Nov 2025 //
FIERCE BIOTECH
Novo Nordisk Submits Updated Proposal To Acquire Metsera
04 Nov 2025 //
GLOBENEWSWIRE
Novo Sharpens India Focus With Bigger Bets On Niche Hospitals
04 Nov 2025 //
ECONOMICTIMES
Lilly, Novo In Obesity Drug Talks With US Government
04 Nov 2025 //
FIERCE PHARMA
Metsera Acknowledges Superior Amended Proposal From Novo Nordisk
04 Nov 2025 //
PR NEWSWIRE
Metsera Issues Statement in Response to Litigation
03 Nov 2025 //
FIERCE BIOTECH
Pfizer Sues Metsera, Directors, And Novo Nordisk Over Merger
31 Oct 2025 //
BUSINESSWIRE
Novo`s CEO Doesn`T Seem To Mind Being Big Pharma`s Villian
31 Oct 2025 //
BIOSPACE
Pila Pharma Capital Raise Oversubscribed 293% for Obesity Work
30 Oct 2025 //
PHARMIWEB
Novo Nordisk Submits Proposal To Acquire Metsera
30 Oct 2025 //
GLOBENEWSWIRE
Metsera Receives Unsolicited Proposal From Novo Nordisk
30 Oct 2025 //
PR NEWSWIRE
Novo Nordisk to Unveil Wegovy 2.4mg Data at AASLD Meeting
28 Oct 2025 //
PR NEWSWIRE
Novo-Backed Maplight Valued At $787M In Nasdaq Debut
27 Oct 2025 //
REUTERS
Novo Nordisk Chairman Empowered After Board Overhaul
24 Oct 2025 //
REUTERS
Dr Reddy`s Gets Nod To Make Generic Semaglutide For Weight Loss
24 Oct 2025 //
ECONOMICTIMES
Novo Nordisk Board Changes: Expert Comment
23 Oct 2025 //
PHARMIWEB
Novo`s Investor Seizes Board Control in Weight-Loss Drug Battle
22 Oct 2025 //
REUTERS
Novo Nordisk Calls Extraordinary General Meeting
21 Oct 2025 //
GLOBENEWSWIRE
Novo Foundation Replaces Pharma Board Amid Leadership Dispute
21 Oct 2025 //
BIOSPACE
Novo Nordisk Calls Extraordinary Meeting For Board Member
21 Oct 2025 //
GLOBENEWSWIRE
Novo Plots Board Shakeup After Stalemate In Leadership Talks
21 Oct 2025 //
FIERCE PHARMA
Novo`s Rybelsus Gains FDA Expansion To Reduce Risk Of MACE
21 Oct 2025 //
FIERCE PHARMA
Novo Nordisk To Unveil Oral Semaglutide 25mg Data at ObesityWeek
20 Oct 2025 //
PR NEWSWIRE

Market Place
Sourcing Support